Skip to main content

precision medicine

By HIMSS TV | 09:06 am | May 14, 2020
Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.
By HIMSS TV | 10:02 am | April 14, 2020
Deep Dive: By integrating social factors, genomics and medical histories, clinicians are better able to treat patients.
SPONSORED
By PsychU | PsychU | 04:02 pm | April 07, 2020
The advantages to health and human service delivery in a bot workforce include speed, reliability, consistency and cost-effectiveness. Sound too far-fetched for your management team? We would disagree.  
By Laura Lovett | 02:18 pm | November 08, 2019
Insights into personalized genomics can help prevent diseases in outer space. 
By HIMSS TV | 12:04 am | October 11, 2019
DayTwo's metagenomics and gut microbiome database helps connect diabetics and others with evidence-based "food-as-medicine" treatment regimens, explains Josh Stevens, the company's president.
By HIMSS TV | 09:44 am | September 24, 2019
Mark Jackson, VP at NantHealth, was at Health 2.0 looking for new opportunities to bring valuable cloud-based data to physicians at the point of care.
By Leontina Postelnicu | 06:49 am | August 30, 2019
An interview with Hakim Yadi, chief executive and cofounder of Closed Loop Medicine.
By HIMSS TV | 09:07 am | August 07, 2019
Andrew Rebhan, consultant at The Advisory Board, discusses new advances in artificial intelligence, biopsychosocial IT, internet of things, 3D printing, augmented reality and more.
By Dean Koh | 06:27 am | July 15, 2019
The Singapore-MIT Alliance for Research and Technology (SMART), together with A*STAR Institutes and supported by the National Research Foundation (NRF), has launched a new national initiative dubbed Critical Analytics for Manufacturing Personalised-Medicine (CAMP).
By HIMSS TV | 12:35 pm | July 10, 2019
Kalle Killar, deputy secretary general at the Ministry of Social Affairs in Estonia, says that nearly 20% of the country's citizens are gene donors, giving it a very valuable asset for implementing precision medicine.